|
| 骨质疏松症治疗药物研究进展 |
| Research progress of the therapeutic drugs for osteoporosis |
| |
| DOI：10.3969/j.issn.1006-7108.2021.05.029 |
| 中文关键词: 骨质疏松 治疗药物 骨吸收 骨形成 |
| 英文关键词:osteoporosis therapeutic drugs bone formation bone resorption |
| 基金项目: |
|
| 摘要点击次数: 583 |
| 全文下载次数: 457 |
| 中文摘要: |
| 骨质疏松症是一种与增龄相关的代谢性骨病，主要是由成骨细胞介导的骨形成与破骨细胞介导的骨吸收之间的失衡所致。随着骨质疏松症患病率的逐年递增，如何防治骨质疏松已经成为我国重要公共健康问题。目前骨质疏松症治疗药物主要可分为促进骨形成剂和抑制骨吸收剂。本文主要就骨质疏松症治疗药物的研究进展作一综述，为临床治疗骨质疏松症提供理论基础。 |
| 英文摘要: |
| Osteoporosis is an age-related metabolic bone disease that is mainly caused by an imbalance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. With the increasing prevalence of osteoporosis, how to prevent and treat osteoporosis has become an important public health problem in China. At present, the drugs for the treatment of osteoporosis can be mainly divided into promoting bone formation agents and inhibiting bone resorption agents. This article mainly reviews the research progress of therapeutic drugs for osteoporosis in order to provide theoretical basis for clinical treatment of osteoporosis. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |